Management of lymph nodes in endometrioid uterine cancer

Current Opinion in Oncology

Volumn 22, Issue 5, 2010, Pages 487-491

  Delpech, Yann ^a   Barranger, Emmanuel ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

early stage; endometrial cancer; lymphadenectomy; morbidity; survival

Indexed keywords

BRACHYTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RISK; CANCER STAGING; CARCINOMA; CLINICAL TRIAL; CYSTIC LYMPHANGIOMA; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; EYE; FROZEN SECTION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYSTERECTOMY; ILEUS; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LYMPH NODE; LYMPHADENECTOMY; LYMPHADENOPATHY; MORBIDITY; PARAAORTIC LYMPH NODE; PELVIS; PELVIS LYMPH NODE; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; RISK; SALPINGOOOPHORECTOMY; SMALL INTESTINE OBSTRUCTION; STANDARD; SURVIVAL; UTERUS CANCER; VALIDATION STUDY;

CARCINOMA, ENDOMETRIOID; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; PROGNOSIS; UTERINE CERVICAL NEOPLASMS;

EID: 77955414613     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32833b9b75     Document Type: Review

References (47)

1. Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet 2005; 366:491-505.
2. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet 2000; 355:1404-1411.
3. Papanikolaou A, Kalogiannidis I, Goutzioulis M, et al. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endome-trial cancer. Arch Gynecol Obstet 2006; 274:91-96.
4. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 1987; 60:2035-2041.
5. Chi DS, Barakat RR, Palayekar MJ, et al. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer 2008; 18:269-273.
6. Chuang L, Burke TW, Tornos C, et al. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol 1995; 58:189-193.
7. Cragun JM, Havrilesky LJ, Calingaert B, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 2005; 23:3668-3675.
8. Kadar N, Homesley HD, Malfetano JH. Prognostic factors in surgical stage III and IV carcinoma of the endometrium. Obstet Gynecol 1994; 84:983-986.
9. McMeekin DS, Lashbrook D, Gold M, et al. Analysis of FIGO Stage IIIc endometrial cancer patients. Gynecol Oncol 2001; 81:273-278.
10. Nelson G, Randall M, Sutton G, et al. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Gynecol Oncol 1999; 75:211-214.
11. Partridge EE, Shingleton HM, Menck HR. The National Cancer Data Base report on endometrial cancer. J Surg Oncol 1996; 61:111-123.
12. Ben-Shachar I, Pavelka J, Cohn DE, et al. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol 2005; 105:487-493.
13. Frumovitz M, Singh DK, Meyer L, et al. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 2004; 95:463-468.
14. Mohan DS, Samuels MA, Selim MA, et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 1998; 70:165-171.
15. Takeshima N, Hirai Y, Tanaka N, et al. Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion. Obstet Gynecol 1996; 88:280-282.
16. Kucera E, Kainz C, Reinthaller A, et al. Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma. Gynecol Obstet Invest 2000; 49:62-66.
17. Obermair A, Geramou M, Gucer F, et al. Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings atsubsequent hysterectomy. IntJ Gynecol Cancer 1999; 9:383-386.
18. Bernardini MQ, Murphy JK. Issues surrounding lymphadenectomy in the management of endometrial cancer. J Surg Oncol 2009; 99:232-241.
19. Kinkel K, Kaji Y, Yu KK, et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999; 212:711-718.
20. Case AS, Rocconi RP, Straughn JM Jr, et al. A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet Gynecol 2006; 108:1375-1379.
21. Mariani A, Webb MJ, Keeney GL, et al. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000; 182: 1506-1519.
22. Girardi F, Petru E, Heydarfadai M, et al. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol 1993; 49:1 77-180.
23. Kilgore LC, Partridge EE, Alvarez RD, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995; 56:29-33.
24. Trimble EL, Kosary C, Park RC. Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 1998; 71:340-343.
25. Carey MS, O'Connell GJ, Johanson CR, et al. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol 1995; 57:138-144.
26. Eltabbakh GH, Piver MS, Hempling RE, Shin KH. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys 1997; 38:373-380.
27. Kitchener H, Swart AM, Qian Q, et al. Efficacy of systematic pelvic lympha-denectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009; 373:125-136.
28. Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lympha-denectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008; 100:1707-1716.
29. Blake P, Swart AM, Orton J, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 rando mised trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009; 373:137-146.
30. Chan JK, Cheung MK, Huh WK, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12 333 patients. Cancer 2006; 107:1823-1830.
31. Lutman CV, Havrilesky LJ, Cragun JM, et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 2006; 102:92-97.
32. Mariani A, Dowdy SC, Cliby WA, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008; 109:11-18.
33. Yokoyama Y, Maruyama H, Sato S, Saito Y. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol 1997; 64:411-417.
34. May K, Bryant A, Dickinson HO, et al. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev 2010. doi: CD007585.
35. Larson DM, Johnson KK. Pelvic and para-aortic lymphadenectomy for surgical staging of high-risk endometrioid adenocarcinoma of the endometrium. Gynecol Oncol 1993; 51:345-348.
36. McMeekin DS, Lashbrook D, Gold M, et al. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. Gynecol Oncol 2001; 82:375-379.
37. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage Iand II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991; 40:55-65.
38. Chan JK, Wu H, Cheung MK, et al. The outcomes of 27 063 women with unstaged endometrioid uterine cancer. Gynecol Oncol 2007; 106:282-288.
39. Todo Y, Kato H, Kaneuchi M, et al. Survival effect of para-aortic lymphade-nectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010; 375:1165-1172.
40. Fujimoto T, Nanjyo H, Nakamura A, et al. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer. Gynecol Oncol 2007; 107:253-259.
41. Dowdy SC, Mariani A. Lymphadenectomy in endometrial cancer: when, not if. Lancet 2010; 375:1138-1140.
42. Orr JW Jr, Holimon JL, Orr PF. Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol 1997; 176:777-788; discussion 788-1779.
43. Eltabbakh GH, Shamonki MI, Moody JM, Garafano LL. Hysterectomy for obese women with endometrial cancer: laparoscopy or laparotomy? Gynecol Oncol 2000; 78:329-335.
44. Holub Z, Jabor A, Kliment L, et al. Laparoscopic hysterectomy in obese women: a clinical prospective study. Eur J Obstet Gynecol Reprod Biol 2001; 98:77-82.
45. Obermair A, Manolitsas TP, Leung Y, et al. Total laparoscopic hysterectomy versus total abdominal hysterectomy for obese women with endometrial cancer. Int J Gynecol Cancer 2005; 15:319-324. (Pubitemid 40396972)
46. Querleu D, Leblanc E, Cartron G, et al. Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patients. Am J Obstet Gynecol 2006; 195:1287-1292.
47. Walker JL, Piedmonte MR, Spirtos NM, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol 2009; 27: 5331-5336